Article
Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.
PLoS medicine - 1 Oct 2009
McIntyre James A, Hopley Mark, Moodley Daya, Eklund Marie, Gray Glenda E, Hall David B, Robinson Patrick, Mayers Douglas, Martinson Neil A
Abstract excerpt
BACKGROUND: Single-dose nevirapine (sdNVP)-which prevents mother-to-child transmission of HIV-selects non-nucleoside reverse-transcriptase inhibitor (NNRTI) resistance mutations in the majority of women and HIV-infected infants receiving it. This open-label, randomised trial examined the efficacy of short-course zidovudine (AZT) and lamivudine (3TC) with sdNVP in reducing NNRTI resistance in mothers, and as a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
